Department of Internal Medicine

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Stents Medicine & Life Sciences
Korea Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Stomach Neoplasms Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Atrial Fibrillation Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug-Eluting Stents Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

Photo of SangHoon Ahn

SangHoon Ahn

Person: Academic

19992019
Photo of Hyuk-Jae Chang

Hyuk-Jae Chang

Person: Academic

20032018
Photo of JaeHee Cheon

JaeHee Cheon

Person: Academic

20042018

Research Output 1981 2019

Antithrombotic Medication and the Risk of Vitreous Hemorrhage in Atrial Fibrillation: Korean National Health Insurance Service National Cohort

Kim, K. E., Yang, P. S., Jang, E., Kim, S. & Joung, B., 2019 Jan 1, In : Yonsei medical journal. 60, 1, p. 65-72 8 p.

Research output: Contribution to journal › Article

Vitreous Hemorrhage
National Health Programs
Warfarin
Atrial Fibrillation
Platelet Aggregation Inhibitors

Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis (Digestive Diseases and Sciences, (2018), 63, 12, (3487-3497), 10.1007/s10620-018-5251-9)

Ahn, S., Marcellin, P., Ma, X., Caruntu, F. A., Tak, W. Y., Elkhashab, M., Chuang, W. L., Tabak, F., Mehta, R., Petersen, J., Guyer, W., Jump, B., Chan, A., Subramanian, M., Crans, G., Fung, S., Buti, M., Gaeta, G. B., Hui, A. J., Papatheodoridis, G. & 2 othersFlisiak, R. & Chan, H. L. Y., 2019 Jan 1, In : Digestive diseases and sciences. 64, 1, p. 285-286 2 p.

Research output: Contribution to journal › Comment/debate

Tenofovir
Hepatitis B Surface Antigens
Genotype
Safety
DNA

Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers

Kim, H. S., Baatarkhuu, O., Lee, H. W., Park, J., kim, D., Ahn, S., Song, K., Han, K., Kim, B. K. & Kim, S., 2019 Jan 1, In : Liver International. 39, 1, p. 81-89 9 p.

Research output: Contribution to journal › Article

Chronic Hepatitis B
Fibrosis
Liver
Pharmaceutical Preparations
Hepatocellular Carcinoma

Press / Media

Hak Seo Kang of Hyundai Steel Company in second quartile of Large MCap CEO Scorecard for past quarter

doyoung kim, Do Hyang Kim & Seok Young Oh

18/6/21 → 19/1/16

2 items of media coverage

Press/Media: Press / Media

Eun Ho Seung of DONGWHA ENTERPRISE in top quartile of Mid Cap Chairmen Scorecard for past quarter

Jin Kim & Jinseok Kim

19/1/14

1 item of media coverage

Press/Media: Press / Media

GSE124663 Universal correction of blood coagulation factor VIII in patient-derived induced pluripotent stem cells using CRISPR/Cas9

Se-Bum Park & YongBeom Park

19/1/5

1 item of media coverage

Press/Media: Press / Media